Cited by 186Anesthesia and Pain ManagementCancer, Stress, Anesthesia, and Immune ResponsePain Management and Opioid Use

Perioperative Intravenous Lidocaine Decreases the Incidence of Persistent Pain After Breast Surgery

Grigoras, Anca, Lee, Peter, Sattar, Faisal, Shorten, George·2012·The Clinical Journal of Pain

Abstract

OBJECTIVES: Breast cancer surgery is associated with a high incidence of persistent postsurgical pain (PPSP). The aim of this study was to evaluate the impact of intravenous (IV) lidocaine on acute and PPSP, analgesic requirements, and sensation abnormalities in patients undergoing surgery for breast cancer. METHODS: Thirty-six patients participated in this randomized, double-blinded study. Before induction of general anesthesia, patients received a bolus of intravenous lidocaine 1.5 mg/kg followed by a continuous infusion of lidocaine 1.5 mg/kgh (lidocaine group) or an equal volume of saline (control group). The infusion was stopped 1 hour after the skin closure. Pain scores and analgesic consumption were recorded at 2, 4, 24 hours, and then daily for 1 week postoperatively. Three months later, patients were assessed for PPSP and secondary hyperalgesia. RESULTS: Two (11.8%) patients in the lidocaine group and 9 (47.4%) patients in the control group reported PPSP at 3 months follow-up (P=0.031). McGill Pain Questionnaire revealed greater present pain intensity-visual analog scale in the control group (14.6 ± 22.5 vs. 2.6 ± 7.5; P=0.025). Secondary hyperalgesia (area of hyperalgesia/length of surgical incision) was significantly less in the lidocaine group compared with control group (0.2 ± 0.8 vs. 3.2 ± 4.5 cm; P=0.002). The 2 groups were similar in terms of analgesic consumption during the early postoperative period. DISCUSSION: Intravenous perioperative lidocaine decreases the incidence and severity of PPSP after breast cancer surgery. Prevention of the induction of central hyperalgesia is a potential mechanism.

Integrity signals

Registry

Crossref · 10.1097/ajp.0b013e31823b9cc8

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Intraoperative intravenous lidocaine infusion is effective for prevention of CPSP after breast cancer surgery.

    “An intraoperative, intravenous, lidocaine infusion has been found to be effective for the prevention of CPSP after breast cancer surgery in a study conducted by Grigoras et al.”
  • In Grigoras et al.'s study, lidocaine significantly reduced the incidence and severity of CPSP at 3 months postoperatively (P = 0.031).

    “They found a significant reduction in the incidence and severity of CPSP with lidocaine at 3 months postoperatively (P = 0.031) [41].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Grigoras, A., Lee, P., Sattar, F., & Shorten, G.
Affiliations
University College Cork (IE)
Venue
The Clinical Journal of Pain
Published
2012-09
Volume
28
Issue
7
Pages
567-572
ISSN
0749-8047 (ISSN-L)
OpenAlex
W2059055540
Cited by
186
References
38
Citations by year
2026: 7 · 2025: 5 · 2024: 6 · 2023: 5 · 2022: 11 · 2021: 14 · 2020: 9 · 2019: 12 · 2018: 17 · 2017: 20 · 2016: 15 · 2015: 19 · 2014: 16 · 2013: 24 · 2012: 4
FWCI
20.52
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Journal of Pain (publishedVersion)
  • PubMed (publishedVersion)
  • Lenus, The Irish Health Repository (Dr Steevens Hospital Library) (submittedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Anesthesia and Pain Management
  • Health Sciences › Medicine › Psychiatry and Mental health › Cancer, Stress, Anesthesia, and Immune Response
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
Keywords
intravenous lidocaine, chronic postoperative pain, breast cancer surgery, perioperative analgesia, secondary hyperalgesia, analgesic use, postoperative pain prevention
MeSH terms
Adult, Aged, Anesthetics, Local, Back Pain, Breast Neoplasms, Chronic Disease, Double-Blind Method, Drug Administration Schedule, Female, Humans, Hyperalgesia, Lidocaine, Middle Aged, Pain, Pain Measurement, Postoperative Complications, Prospective Studies, Time Factors, Incidence, Administration, Intravenous

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review